CClinicalTrials.gg
RecruitingNCT06808399ASYMRUNUpdated Feb 5, 2025

The Magnitude of Inter-limb Asymmetry and Its Assocation with Inter-limb Asymmetry in Distance Runners and Non-runners

An observational study in Healthy, sponsored by Vrije Universiteit Brussel. Recruiting at 1 site in Belgium. Open to participants aged 20 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-05.

Sponsored by Vrije Universiteit Brussel · Observational

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 4 months ago, but the record still lists the study as recruiting.
  • Started Jan 2023; still recruiting 3 years 9 months later.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
72
Ages
20 Years to 50 Years
Sex
All
01

Study summary

Distance running is one of the most popular and most accessible ways to engage in physical activity. Although distance running offers numerous health-related benefits and protects against noncommunicable diseases (e.g., type 2 diabetic, obesity, hypertension), research has indicated a high prevalence of running-related injuries with a more pronounced incidence among novice runners (i.e., 17.8 injuries per 1000h) compared to their highly trained peers (i.e., 7.2 injuries per 1000h).

Interlimb asymmetry has previously been related to higher injury risk as well as to impaired sports performances. Nevertheless, to date, research on the degree and evolution of functional asymmetry (e.g., unequal strength between limbs) in distance runners is scarce and the role of functional asymmetries in running performance and running-related injuries remains unclear. Moreover, and despite the great number of unilateral tests available in the literature, there currently exists no reliable and run-specific field-based test battery to examine the degree of lower limb asymmetry in distance runners. Therefore, this study aims to assess the test-retest, intra- and inter-rater reliability of a newly created running-specific field-based test battery to assess the presence and degree of functional lower limb asymmetry among novice, moderatly and highly trained distance runners as well as a control group of non-athletes. The second objective is to assess the association between inter-limb asymmetry and running performance.

02

Conditions studied

  • Healthy
03

In context

Lead sponsor

Vrije Universiteit Brussel is the lead sponsor of 154 studies on the registry; 43 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Healthy population (see eligibility criteria)

Inclusion criteria

    • Being aged between 20 and 50 years at Tfamiliarization

      • Being free from any medical attention injury (i.e., injury that results in a participant receiving medical attention) for at least 6 months upon Tfamiliarization
      • Speaking Dutch, French or English
  • Highly trained distance runners:

    • Running at least 150km per month for at least 3 months

Moderately-trained runners:

  • Running between 40 - 150 km per month for at least 6 months

    • Novice distance runners:
  • Running not more than 10km per week for the past 12 months

    • Control group of non-athletes
  • Performing \<75min of systematic moderate to vigorous-intensity physical activity per week and having no experience in systematic (un)structured running activities for the past 5 years

Exclusion criteria

Exclusion Criteria:

    • Being younger than 20 years or older than 50 years at Tfamiliarization

      • Any known relevant medical history or current condition (e.g., neurological diseases, inner ear diseases) that could affect the performance of the functional tests (e.g., balance in repeated hop tests)
      • Participants that have undergone a surgery at lower limb level during the past 6 months
      • Medication or drug use (e.g., blood pressure medicines)that could affect the performance of the functional tests (e.g., balance in repeated hop tests)
      • Participants performing more than two hours per week of unilateral sports (e.g., tennis or soccer)
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
72 participants (estimated)
Patient registry
No

Groups and cohorts

  • Highly-trained distance runners

    This study is an observational study and not an interventional study.

  • Novice distance runners

    This study is an observational study and not an interventional study.

  • Non-Athletes

    This study is an observational study and not an interventional study.

  • Moderately trained distance runners

    This study is an observational study and not an interventional stud

06

What researchers measure

Primary outcomes

  1. Lean mass

    Measured using dual-energy X-ray absorptiometry.

    Time frame: Baseline

  2. Fat mass

    Measured using dual-energy X-ray absorptiometry.

    Time frame: Baseline

  3. Bone mineral density

    Measured using dual-energy X-ray absorptiometry.

    Time frame: Baseline

  4. Phase angle

    Measured using bioelectrical impedance analysis.

    Time frame: Baseline

  5. Lean mass

    Measured using bioelectrical impedance analysis.

    Time frame: Baseline

  6. Fat mass

    Measured using bioelectrical impedance analysis.

    Time frame: Baseline

  7. Total segmental water

    Measured using bioelectrical impedance analysis.

    Time frame: Baseline

  8. Extracellular water

    Measured using bioelectrical impedance analysis.

    Time frame: Baseline

  9. 5 repeated vertical hop test.

    Measured using an Optojump device

    Time frame: 3 test occasions: baseline, 2 weeks after baseline and 4 weeks after baseline.

  10. 5 repeated horizontal hop test

    Measured using an Optojump device

    Time frame: 3 test occasions: baseline, 2 weeks after baseline and 4 weeks after baseline.

  11. ankle dorsiflexion range of motion

    The maximal dorsiflexion range of motion (cm from a wall) will be measured with tape measure.

    Time frame: 3 test occasions: baseline, 2 weeks after baseline and 4 weeks after baseline.

  12. Side bridge endurance test

    The side bridge endurance test will be carried out in which, the participants will lie on one side of the body fully extended (i.e., hip and torso at 0°) in a plank position with the feet elevated on a 15-cm step and with the superior feet placed in front. The participants will be instructed to lift the hips until the body is in straight position with the arms folded across the chest. The time until a drop (lasting more than 3s) of the hips from the optimal position will manually be recorded. To control for a full range of motion upon the execution of this muscle capacity tests, a reference dowel will be used to indiciate the desired range of motion.

    Time frame: 3 test occasions: baseline, 2 weeks after baseline and 4 weeks after baseline.

  13. Hip adduction strength

    Measured with a handheld dynamometer.

    Time frame: 3 test occasions: baseline, 2 weeks after baseline and 4 weeks after baseline.

  14. Hip abduction strength

    Measured using a hand-held dynamometer.

    Time frame: 3 test occasions: baseline, 2 weeks after baseline and 4 weeks after baseline.

  15. Knee extension strength

    Measured using a hand-held dynamometer.

    Time frame: 3 test occasions: baseline, 2 weeks after baseline and 4 weeks after baseline.

  16. Knee flexion strength

    Measured using a hand-held dynamometer.

    Time frame: 3 test occasions: baseline, 2 weeks after baseline and 4 weeks after baseline.

  17. Ankle dorsiflexion strength

    Measured using a hand-held dynamometer.

    Time frame: 3 test occasions: baseline, 2 weeks after baseline and 4 weeks after baseline.

  18. Ankle plantar flexion strength

    Measured using a hand-held dynamometer.

    Time frame: 3 test occasions: baseline, 2 weeks after baseline and 4 weeks after baseline.

  19. Cooper test

    Maximal distance covered in 12 minutes.

    Time frame: This test will be carried out on the second test occasion (two weeks after baseline).

  20. Training volume

    Surveyed with an online questionnaire and quantified in hours/week (per sport performed).

    Time frame: Baseline

  21. Contact time while running

    Measures with an Optojump device

    Time frame: This test will be carried out on the third test occasion (four weeks after baseline).

  22. Flight time while running

    Measured using an Optojump device.

    Time frame: This test will be carried out on the third test occasion (four weeks after baseline).

  23. Stride length

    Measured using an Optojump device.

    Time frame: This test will be carried out on the third test occasion (four weeks after baseline).

Secondary outcomes

  1. Weight

    Time frame: Baseline

  2. Height

    Time frame: Baseline

  3. Leg length

    Measured using dual-energy X-ray absorptiometry and a tape measure.

    Time frame: Baseline

  4. Bone mineral content

    Measured busing dual-energy X-ray absorptiometry.

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
  • MOVE Research group
    Elsene, Brussel 1050, Belgium
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 5, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06808399
Lead sponsor
Vrije Universiteit Brussel
Responsible party
Joachim D'Hondt (PhD Researcher, Vrije Universiteit Brussel) — Principal investigator
First posted
Feb 5, 2025
Start date
Jan 1, 2023
Primary completion
Jun 1, 2025 (estimated)
Completion
Jun 1, 2025 (estimated)
Last update
Feb 5, 2025

Study contacts

Joachim D'Hondt
Contact
Joachim.dhondt@vub.be
+32 (0) 629 27 35

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion